MedPath

Bendroflumethiazide

Generic Name
Bendroflumethiazide
Drug Type
Small Molecule
Chemical Formula
C15H14F3N3O4S2
CAS Number
73-48-3
Unique Ingredient Identifier
5Q52X6ICJI

Overview

A thiazide diuretic with actions and uses similar to those of hydrochlorothiazide. It has been used in the treatment of familial hyperkalemia, hypertension, edema, and urinary tract disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p810)

Background

A thiazide diuretic with actions and uses similar to those of hydrochlorothiazide. It has been used in the treatment of familial hyperkalemia, hypertension, edema, and urinary tract disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p810)

Indication

For the treatment of high blood pressure and management of edema related to heart failure.

Associated Conditions

  • Hypertension

FDA Drug Approvals

Approved Product
Manufacturer
NDC Code
Route
Strength
Effective Date
Impax Generics
0115-5322
ORAL
5 mg in 1 1
4/15/2016
Impax Generics
0115-5311
ORAL
5 mg in 1 1
4/15/2016

EMA Drug Approvals

Approved Product
Authorization Holder
Status
Issued Date
No EMA approvals found for this drug.

HSA Drug Approvals

Approved Product
Manufacturer
Approval Number
Dosage Form
Strength
Approval Date
No HSA approvals found for this drug.

NMPA Drug Approvals

Approved Product
Company
Approval Number
Drug Type
Dosage Form
Approval Date
Bendroflumethiazide Tablets
国药准字H11021717
化学药品
片剂
11/27/2020

PPB Drug Approvals

Approved Product
Registration No.
Company
Licence No.
Strength
Registration Date
No PPB approvals found for this drug.

TGA Drug Approvals

Approved Product
ARTG ID
Sponsor
Registration Type
Status
Registration Date
No TGA approvals found for this drug.
© Copyright 2025. All Rights Reserved by MedPath